Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maja Svensson"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background There is still a profound lack of efficient therapeutic strategies against pancreatic and other periampullary adenocarcinoma. Surgery is seldom possible, leaving palliative chemotherapy the only option for most patients. Chemother
Externí odkaz:
https://doaj.org/article/0d63736a14b845a9989987c448ca1b6e
Autor:
Maria C. Svensson, Maja Svensson, Björn Nodin, David Borg, Charlotta Hedner, Claes Hjalmarsson, Karin Leandersson, Karin Jirström
Publikováno v:
Journal of Innate Immunity, Pp 1-14 (2022)
Tumor-associated macrophages (TAMs) have emerged as key players in tumor immunology but demonstrate a continuum of functional states being either tumor suppressive or promoting. Moreover, chemotherapeutic agents have been shown to alter the tumor mic
Externí odkaz:
https://doaj.org/article/c40cd281455e4ca2844560d7cd6332d3
Publikováno v:
SSRN Electronic Journal.
Autor:
Maria C, Svensson, Maja, Svensson, Björn, Nodin, David, Borg, Charlotta, Hedner, Claes, Hjalmarsson, Karin, Leandersson, Karin, Jirström
Publikováno v:
Journal of innate immunity. 14(6)
Tumor-associated macrophages (TAMs) have emerged as key players in tumor immunology but demonstrate a continuum of functional states being either tumor suppressive or promoting. Moreover, chemotherapeutic agents have been shown to alter the tumor mic
Autor:
Maja Svensson, Alexandra Petersson, Viktor Sincic, Sofie Olsson Hau, Jakob Eberhard, David Gisselsson Nord, Karin Leandersson, Kristina Lundberg, Karin Jirström
Publikováno v:
Cancer Research. 82:A022-A022
Pancreatic cancer (PC) has become one of the leading causes of cancer related deaths. Late detection and resistance to therapy are two reasons for the dismal prognosis of this disease. Hence, there is an immense need for novel treatment options as we
Autor:
Maja Svensson, Anders Bjartell, Leif Jørgensen, Annica Löfgren, Mohammed Alghazali, Karin Fagerlund
Publikováno v:
Scandinavian journal of urology. 53(5)
Objective: This retrospective, single-centre, non-interventional, registry-based study evaluated patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide in daily clinical practice at Skåne University Hospital,
Publikováno v:
The Aging Male. 20:266-276
Treating male lower urinary tract symptoms (LUTS) by targeting the prostate would have limited effect on overactive bladder (OAB) symptoms. This study assessed perceived symptoms and quality of life (QoL) of male patients with OAB treated with an α-
Publikováno v:
Scandinavian journal of urology. 53(4)
Aim: To describe treatment patterns in Denmark, Norway and Sweden for patients receiving overactive bladder (OAB) pharmacotherapy. Methods: This was a prospective, multinational, registry-based study involving three nationwide prescribed drug registr